Home / Resource Library / Significant weight gain in CLL patients treated with Ibrutinib: A potentially deleterious consequence of therapy

Significant weight gain in CLL patients treated with Ibrutinib: A potentially deleterious consequence of therapy

Results of an observational study investigating weight gain as a side effect of treatment with ibrutinib.